{"altmetric_id":3795202,"counts":{"readers":{"mendeley":138,"citeulike":1,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["364089560357222"],"posts_count":1},"googleplus":{"unique_users_count":1,"unique_users":["Advantage Integral"],"posts_count":1},"news":{"unique_users_count":15,"unique_users":["bioportfolio","ad_hoc_news","justaforum","innovations_report","today_topics","medical_news_today","health_medicinet","the_medical_news","medicalxpress","health_canal","technobahn","science_newsline","science_daily","eurekalert","informationsdienst_wissenschaft"],"posts_count":17},"total":{"posts_count":80},"twitter":{"unique_users_count":44,"unique_users":["Robot_Insect","THebertMcGill","MHendr1cks","Al_Khafor","Studentsos","VyasRamanan","Pharma_Mty","Bird_leahry","PiescheM","Biotech_Bio","Immune_News","SjogrensForum","DrFerdowsi","FutSciNow","NextGEN_Ltd","PDRennert","HimaniTrivedi17","mrsgkr","melanienaidoo_2","SantaCruzBio","sjin_lee","ivdacruz","BIOCIENCIA2013","Mykalt45","MonzCobak","perepereden","RTandBT","dhovekamp42","PrivilegeHealth","celltherapynews","BuckeyeMyeloma","Cytognos","JohnMakotoM","Quantumash","yannabraham","papa_cannolo","xiangfang_n","isciencewriter","DrSuePearson","CancerWallonia","fsgfon","Molecutools","iRecRepPapers","TumorImm_papers"],"posts_count":57},"weibo":{"unique_users_count":4,"unique_users":["\u7d2b\u5cf0\u8428\u6469\u8036","\u5e03\u9053\u78a7\u6d6a","\u6765\u90a6\u7f51","\u7099\u94ed\u548f\u6625"],"posts_count":4}},"selected_quotes":["Identification of human TCRs with affinity to cancer antigens using antigen-negative humanized mice","Identification of human T-cell receptors with affinity to cancer antigens using antigen-negative humanized mice","Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-neg humanized mice","Great concept:Identif. of human T-cell receptors w affinity 2 #cancer #antigens using antigen-negative humanized mice"],"citation":{"abstract":"Identifying T-cell receptors (TCRs) that bind tumor-associated antigens (TAAs) with optimal affinity is a key bottleneck in the development of adoptive T-cell therapy of cancer. TAAs are unmutated self proteins, and T cells bearing high-affinity TCRs specific for such antigens are commonly deleted in the thymus. To identify optimal-affinity TCRs, we generated antigen-negative humanized mice with a diverse human TCR repertoire restricted to the human leukocyte antigen (HLA) A*02:01 (ref. 3). These mice were immunized with human TAAs, for which they are not tolerant, allowing induction of CD8+ T cells with optimal-affinity TCRs. We isolate TCRs specific for the cancer\/testis (CT) antigen MAGE-A1 (ref. 4) and show that two of them have an anti-tumor effect in vivo. By comparison, human-derived TCRs have lower affinity and do not mediate substantial therapeutic effects. We also identify optimal-affinity TCRs specific for the CT antigen NY-ESO. Our humanized mouse model provides a useful tool for the generation of optimal-affinity TCRs for T-cell therapy.","abstract_source":"pubmed","altmetric_jid":"4f6fa50a3cf058f610003162","authors":["Matthias Obenaus","Catarina Leit\u00e3o","Matthias Leisegang","Xiaojing Chen","Ioannis Gavvovidis","Pierre van der Bruggen","Wolfgang Uckert","Dolores J Schendel","Thomas Blankenstein","Obenaus M","Leit\u00e3o C","Leisegang M","Chen X","Gavvovidis I","van der Bruggen P","Uckert W","Schendel DJ","Blankenstein T"],"doi":"10.1038\/nbt.3147","first_seen_on":"2015-03-16T18:49:59+00:00","funders":["niehs"],"issns":["1087-0156","1546-1696"],"issue":"4","journal":"Nature Biotechnology","last_mentioned_on":1467305523,"links":["http:\/\/www.nature.com\/nbt\/journal\/vaop\/ncurrent\/full\/nbt.3147.html","http:\/\/feeds.nature.com\/~r\/nbt\/rss\/aop\/~3\/L20DwPfyS0A\/nbt.3147","http:\/\/dx.doi.org\/10.1038\/nbt.3147","http:\/\/www.nature.com\/nbt\/journal\/vaop\/ncurrent\/full\/nbt.3147.html?utm_content=buffer22849&utm_medium=social&utm_source=plus.google.com&utm_campaign=buffer","http:\/\/www.nature.com\/nbt\/journal\/vaop\/ncurrent\/nbt.3147\/metrics","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25774714","http:\/\/www.nature.com\/doifinder\/10.1038\/nbt.3147","http:\/\/www.nature.com\/nbt\/journal\/v33\/n4\/full\/nbt.3147.html","http:\/\/www.nature.com\/nbt\/journal\/v33\/n4\/full\/nbt.3147.html#affil-auth","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25774714?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pmid":"25774714","pubdate":"2015-03-16T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Translational research","scheme":"npg"},{"name":"Immunotherapy","scheme":"npg"},{"name":"Cancer immunotherapy","scheme":"npg"},{"name":"Multidisciplinary","scheme":"era"}],"scopus_subjects":["Life Sciences","Chemical Engineering","Engineering","Immunology and Microbiology","Physical Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["biotechnology"],"title":"Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice","type":"article","volume":"33","mendeley_url":"http:\/\/www.mendeley.com\/research\/identification-human-tcell-receptors-optimal-affinity-cancer-antigens-using-antigennegative-humanize"},"altmetric_score":{"score":140.3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":140.3},"context_for_score":{"all":{"total_number_of_other_articles":8430032,"mean":7.0911118469117,"rank":56917,"this_scored_higher_than_pct":99,"this_scored_higher_than":8373181,"rank_type":"exact","sample_size":8430032,"percentile":99},"similar_age_3m":{"total_number_of_other_articles":204850,"mean":9.5135508008338,"rank":2138,"this_scored_higher_than_pct":98,"this_scored_higher_than":202711,"rank_type":"exact","sample_size":204850,"percentile":98},"this_journal":{"total_number_of_other_articles":4043,"mean":25.017004948046,"rank":138,"this_scored_higher_than_pct":96,"this_scored_higher_than":3905,"rank_type":"exact","sample_size":4043,"percentile":96},"similar_age_this_journal_3m":{"total_number_of_other_articles":103,"mean":31.479901960784,"rank":4,"this_scored_higher_than_pct":96,"this_scored_higher_than":99,"rank_type":"exact","sample_size":103,"percentile":96}}},"demographics":{"poster_types":{"member_of_the_public":35,"researcher":6,"practitioner":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":35,"Scientists":6,"Practitioners (doctors, other healthcare professionals)":2,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":4,"Researcher":43,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":35,"Student  > Postgraduate":5,"Other":16,"Student  > Master":15,"Student  > Bachelor":8,"Professor":3},"by_discipline":{"Engineering":6,"Medicine and Dentistry":23,"Chemistry":5,"Immunology and Microbiology":15,"Agricultural and Biological Sciences":58,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":21,"Unspecified":4,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"CA":1,"GB":3,"US":5,"CL":1,"ZA":1,"VE":1,"MX":1,"ES":1,"JP":1,"BE":1,"IT":1,"IE":1},"weibo":{"CN":1},"mendeley":{"US":6,"CN":1,"GB":1,"DE":1,"RU":1}}},"posts":{"news":[{"title":"Identification of human Tcell receptors with optimal affinity to cancer antigens using antigennegative humanized mice","url":"http:\/\/www.bioportfolio.com\/news\/article\/2263920\/Identification-of-human-T-cell-receptors-with-optimal-affinity-to-cancer-antigens.html","license":"public","citation_ids":[3795202],"posted_on":"2015-03-17T01:13:01+00:00","summary":"A humanized mouse model facilitates the identification of T cell receptors for unmutated cancer antigens.","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}},{"title":"Medigene gibt Publikation in \"Nature Biotechnology\" zu TCR-Entwicklung bekannt","url":"http:\/\/www.ad-hoc-news.de\/medigene-gibt-publikation-in-and-quot-nature-biotechnology-and-quot-zu-tcr--\/de\/News\/42523741","license":"public","citation_ids":[3795202],"posted_on":"2015-03-17T05:42:25+00:00","summary":"","author":{"name":"Ad Hoc News","url":"http:\/\/www.ad-hoc-news.de\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/201\/normal\/image.jpeg?1370251863"}},{"title":"Medigene announces publication in \"Nature Biotechnology\" on TCRdevelopment","url":"http:\/\/www.bioportfolio.com\/news\/article\/2264245\/Medigene-announces-publication-in-Nature-Biotechnology-on-TCR-development.html","license":"public","citation_ids":[3795202],"posted_on":"2015-03-17T07:39:16+00:00","summary":"Medigene AG Medigene announces publication in &quot;Nature Biotechnology&quot; on TCRdevelopment. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement. Press releaseMartin...","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}},{"title":"MDC- und Charit\u00e9-Forscher sch\u00e4rfen das Immunsystem gegen Krebs","url":"http:\/\/www.juraforum.de\/wissenschaft\/mdc-und-charite-forscher-schaerfen-das-immunsystem-gegen-krebs-510814","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-17T09:10:10+00:00","summary":"[b]Forschern des Max-Delbr\u00fcck-Centrums f\u00fcr Molekulare Medizin (MDC) Berlin-Buch und der Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, ist es gelungen, Zellen des Immunsystems im Labor so aufzur\u00fcsten, dass sie Krebszellen ganz gezielt erkennen u","author":{"name":"Jura Forum","url":"http:\/\/www.juraforum.de\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/187\/normal\/Screen_Shot_2014-10-06_at_11.40.52.png?1412592073"}},{"title":"MDC- und Charit\u00e9-Forscher sch\u00e4rfen das Immunsystem gegen Krebs","url":"http:\/\/www.innovations-report.de\/html\/berichte\/biowissenschaften-chemie\/mdc-und-charite-forscher-schaerfen-das-immunsystem-gegen-krebs.html","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-17T00:00:00+00:00","summary":"Forschern des Max-Delbr\u00fcck-Centrums f\u00fcr Molekulare Medizin (MDC) Berlin-Buch und der Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, ist es gelungen, Zellen des Immunsystems im Labor so aufzur\u00fcsten, dass sie Krebszellen ganz gezielt erkennen und","author":{"name":"Innovations Report","url":"http:\/\/www.innovations-report.de\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/187\/normal\/image.gif?1369925610"}},{"title":"Researchers in Berlin tweak the immune system to target cells bearing tumor antigens","url":"http:\/\/www.todaytopics.com\/researchers-in-berlin-tweak-the-immune-system-to-target-cells-bearing-tumor-antigens\/35856\/","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-23T07:19:01+00:00","summary":"Researchers at the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch and Charite \u2013 Universitatsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"Today Topics ","url":"http:\/\/www.todaytopics.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/290\/normal\/Screen_Shot_2014-11-27_at_12.02.15.png?1417089747"}},{"title":"Researchers in Berlin tweak the immune system to target cells bearing tumor antigens","url":"http:\/\/www.medicalnewstoday.com\/releases\/291210.php","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-23T07:00:00+00:00","summary":"Researchers at the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch and Charite - Universitatsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system...","author":{"name":"Medical News Today","url":"http:\/\/www.medicalnewstoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/040\/normal\/medical_news_today.png?1369846932"}},{"title":"Researchers successfully generate cells of immune system to target, destroy cancer cells","url":"http:\/\/healthmedicinet.com\/news\/researchers-successfully-generate-cells-of-immune-system-to-target-destroy-cancer-cells\/","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-20T10:31:45+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine (MDC) Berlin-Buch and Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"Health Medicinet","url":"http:\/\/healthmedicinet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/942\/normal\/image.png?1402915110"}},{"title":"Researchers successfully generate cells of immune system to target, destroy cancer cells","url":"http:\/\/www.news-medical.net\/news\/20150320\/Researchers-successfully-generate-cells-of-immune-system-to-target-destroy-cancer-cells.aspx","license":"public","citation_ids":[3795202,3795202,216827],"posted_on":"2015-03-20T07:11:45+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine Berlin-Buch and Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells.","author":{"name":"The Medical News","url":"http:\/\/www.news-medical.net\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/146\/normal\/image.png?1369927508"}},{"title":"Researchers tweak the immune system to target cells bearing tumor antigens","url":"http:\/\/medicalxpress.com\/news\/2015-03-tweak-immune-cells-tumor-antigens.html","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-19T13:19:36+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine (MDC) Berlin-Buch and Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"MDC and Charit\u00e9 Researchers Tweak the Immune System to Target Cells Bearing Tumor Antigens","url":"http:\/\/www.healthcanal.com\/immune-system\/61471-mdc-and-charite-researchers-tweak-the-immune-system-to-target-cells-bearing-tumor-antigens.html","license":"public","citation_ids":[216827,3795202],"posted_on":"2015-03-19T11:43:00+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine (MDC) Berlin-Buch and Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"Health Canal","url":"http:\/\/www.healthcanal.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/221\/normal\/image.png?1370446573"}},{"title":"Researchers in Berlin Tweak the Immune System to Target Cells Bearing Tumor Antigens","url":"http:\/\/w2.technobahn.com\/articles\/2015031915150014.html","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-19T15:15:00+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine (MDC) Berlin-Buch and Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"Technobahn","url":"http:\/\/www.technobahn.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/559\/normal\/Screen_Shot_2016-02-03_at_09.22.22.png?1454491354"}},{"title":"Researchers in Berlin Tweak the Immune System to Target Cells Bearing Tumor Antigens","url":"http:\/\/www.sciencenewsline.com\/summary\/2015031915150014.html","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-19T15:15:00+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine (MDC) Berlin-Buch and Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"Science Newsline","url":"http:\/\/www.sciencenewsline.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/245\/normal\/Screen_Shot_2016-02-02_at_17.20.48.png?1454433662"}},{"title":"Researchers tweak the immune system to target cells bearing tumor antigens","url":"http:\/\/www.sciencedaily.com\/releases\/2015\/03\/150319092216.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Ftop_news+%28ScienceDaily%3A+Top+News%29","license":"public","citation_ids":[3795202,216827],"posted_on":"2015-03-19T13:22:16+00:00","summary":"Researchers have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The immune system of the body is trained to distinguish between \"foreign\" and \"self\" and to recognize and destroy exogenous structures. In","author":{"name":"Science Daily","url":"http:\/\/www.sciencedaily.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/179\/normal\/image.png?1369927053"}},{"title":"Researchers in Berlin tweak the immune system to target cells bearing tumor antigens","url":"http:\/\/www.eurekalert.org\/pub_releases\/2015-03\/mdcf-rib031915.php","license":"public","citation_ids":[3795202,216827,3795202],"posted_on":"2015-03-19T04:00:00+00:00","summary":"( Max Delbrueck Center for Molecular Medicine (MDC) Berlin-Buch ) Researchers at the Max Delbr\u00fcck Center Berlin-Buch and Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}},{"title":"MDC and Charit\u00e9 Researchers Tweak the Immune System to Target Cells Bearing Tumor Antigens","url":"https:\/\/idw-online.de\/en\/news627772","license":"public","citation_ids":[3795202,3795202,216827],"posted_on":"2015-03-19T09:43:00+00:00","summary":"Researchers at the Max Delbr\u00fcck Center for Molecular Medicine (MDC) Berlin-Buch and Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Campus Berlin-Buch, have succeeded in generating cells of the immune system to specifically target and destroy cancer cells. The resea","author":{"name":"Informationsdienst Wissenschaft","url":"http:\/\/idw-online.de\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/910\/normal\/image.png?1401445969"}},{"title":"MDC And Charit\u00e9 Researchers Identify Gene Responsible for Hypertension And Brachydactyly","url":"http:\/\/www.sciencenewsline.com\/articles\/2015051117290026.html","license":"public","citation_ids":[3795202],"posted_on":"2015-05-11T17:29:00+00:00","summary":"Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so s","author":{"name":"Science Newsline","url":"http:\/\/www.sciencenewsline.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/245\/normal\/Screen_Shot_2016-02-02_at_17.20.48.png?1454433662"}}],"twitter":[{"url":"https:\/\/twitter.com\/Robot_Insect\/status\/577542090155917313","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-16T18:48:59+00:00","author":{"name":"**Bumblebear**","image":"https:\/\/pbs.twimg.com\/profile_images\/908115267040944130\/s-g3Xz_H_normal.jpg","description":"Entomologist, type 1 diabetic, cat mom, and generally enthusiastic person. Work as professional sales rep in agriculture. Future owner of a Tesla pickup.","id_on_source":"Robot_Insect","tweeter_id":"234554864","geo":{"lt":null,"ln":null},"followers":1570},"tweet_id":"577542090155917313"},{"url":"https:\/\/twitter.com\/THebertMcGill\/status\/577542910419271680","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-16T18:52:14+00:00","author":{"name":"Terry H\u00e9bert","image":"https:\/\/pbs.twimg.com\/profile_images\/3692558110\/d2221dcaa41123dc08b3717e79d90d48_normal.jpeg","description":"Scientist;Interested in drug discovery and cellular signalling- opinions my own","id_on_source":"THebertMcGill","tweeter_id":"1447788685","geo":{"lt":null,"ln":null},"followers":781},"tweet_id":"577542910419271680"},{"url":"https:\/\/twitter.com\/MHendr1cks\/status\/577543608632524800","license":"datasift","rt":["THebertMcGill"],"citation_ids":[3795202],"posted_on":"2015-03-16T18:55:01+00:00","author":{"name":"Michael Hendricks","url":"http:\/\/www.hendrickslab.org","image":"https:\/\/pbs.twimg.com\/profile_images\/898372297039511556\/9zuvbVAX_normal.jpg","description":"Neurobiologist sort of","id_on_source":"MHendr1cks","tweeter_id":"581076102","geo":{"lt":46.81228,"ln":-71.21454,"country":"CA"},"followers":3617},"tweet_id":"577543608632524800"},{"url":"https:\/\/twitter.com\/Al_Khafor\/status\/577544259626082304","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-16T18:57:36+00:00","author":{"name":"ALKHAF\u0648R","image":"http:\/\/pbs.twimg.com\/profile_images\/566590966388101120\/yR8Vlp-t_normal.jpeg","description":"College student believes in #science. I'm interested in: #Astrophysics, #Evolutionary Stuff, #HumanRights, #Economic. I have big dreams & goals in my life.","id_on_source":"Al_Khafor","tweeter_id":"2972343822","followers":42},"tweet_id":"577544259626082304"},{"url":"https:\/\/twitter.com\/Studentsos\/status\/577544704268636160","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-16T18:59:22+00:00","author":{"name":"StudentSOS","url":"http:\/\/studentsos.co.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/581464880064135168\/NTG9xgtq_normal.png","description":"Opening Minds, Opening Doors","id_on_source":"Studentsos","tweeter_id":"2157277149","geo":{"lt":52.51868,"ln":-1.9945,"country":"GB"},"followers":1472},"tweet_id":"577544704268636160"},{"url":"https:\/\/twitter.com\/VyasRamanan\/status\/577545040475611136","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-16T19:00:42+00:00","author":{"name":"Vyas Ramanan","url":"https:\/\/www.linkedin.com\/in\/vyasramanan","image":"https:\/\/pbs.twimg.com\/profile_images\/2022455394\/vr_photo_hst_normal.jpg","description":"Biotech. Packers. Sours. Puns. Not necessarily in that order. I was booed at my thesis defense. By way of @MIT IMES & @pennfishermandt","id_on_source":"VyasRamanan","tweeter_id":"159012668","geo":{"lt":42.3751,"ln":-71.10561,"country":"US"},"followers":542},"tweet_id":"577545040475611136"},{"url":"https:\/\/twitter.com\/Pharma_Mty\/status\/577555544333893632","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-16T19:42:26+00:00","author":{"name":"Jose Hernandez","image":"https:\/\/pbs.twimg.com\/profile_images\/3738713976\/d12e3133940b643bdcdf549ca5dc915f_normal.jpeg","id_on_source":"Pharma_Mty","tweeter_id":"594887988","geo":{"lt":null,"ln":null},"followers":73},"tweet_id":"577555544333893632"},{"url":"https:\/\/twitter.com\/Bird_leahry\/status\/577565593571893249","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-16T20:22:22+00:00","author":{"name":"Larry Bird, PhD","image":"https:\/\/pbs.twimg.com\/profile_images\/551426049717051392\/BpztjnOZ_normal.jpeg","description":"Biologist, technologist, martial artist, cycling enthusiast (not necessarily in that order)","id_on_source":"Bird_leahry","tweeter_id":"2322715397","geo":{"lt":null,"ln":null},"followers":701},"tweet_id":"577565593571893249"},{"url":"https:\/\/twitter.com\/PiescheM\/status\/577588876681818112","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-16T21:54:53+00:00","author":{"name":"Matthias Piesche","url":"http:\/\/Gofundme.com\/immunotherapy","image":"https:\/\/pbs.twimg.com\/profile_images\/585519282508980225\/zir5JDT6_normal.jpg","description":"AssProf @ UCM. @DanaFarber\/@HarvardMed Alumnus. Interested in #cancer immunology & new biotechnologies. #Fundraising for cancer #immunotherapy research","id_on_source":"PiescheM","tweeter_id":"1852946341","geo":{"lt":-35.4264,"ln":-71.65542,"country":"CL"},"followers":1760},"tweet_id":"577588876681818112"},{"url":"https:\/\/twitter.com\/Biotech_Bio\/status\/577595568928751616","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-16T22:21:29+00:00","author":{"name":"Laurent S.","image":"http:\/\/pbs.twimg.com\/profile_images\/553943373623463936\/geOGjAIt_normal.png","description":"#biotech #sant\u00e9 #entrepreneuriat #crowdfunding #capitalrisque #innovation #startup","id_on_source":"Biotech_Bio","tweeter_id":"2306551190","followers":92},"tweet_id":"577595568928751616"},{"url":"https:\/\/twitter.com\/Immune_News\/status\/577578880904638464","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-16T21:15:10+00:00","author":{"name":"ImmuneRegulationNews","url":"http:\/\/www.immuneregulationnews.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1121072009\/ImmuneRegulationNews_normal.jpg","description":"The online resource for the immune regulation community. Check out our sister publications, @InfDisease_News and @HumanImmuneNews.\nFB: http:\/\/ow.ly\/VGAoz","id_on_source":"Immune_News","tweeter_id":"154612604","geo":{"lt":null,"ln":null},"followers":3242},"tweet_id":"577578880904638464"},{"url":"https:\/\/twitter.com\/SjogrensForum\/status\/577642737018626048","license":"datasift","rt":["Immune_News"],"citation_ids":[3795202],"posted_on":"2015-03-17T01:28:55+00:00","author":{"name":"Sj\u00f6grens Forum","url":"http:\/\/www.sjogrensforum.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1083947731\/birds_normal.jpg","description":"Living Well With Sj\u00f6gren's Syndrome.","id_on_source":"SjogrensForum","tweeter_id":"169679081","geo":{"lt":null,"ln":null},"followers":3126},"tweet_id":"577642737018626048"},{"url":"https:\/\/twitter.com\/DrFerdowsi\/status\/577760449577496576","license":"datasift","rt":["DrSuePearson"],"citation_ids":[3795202],"posted_on":"2015-03-17T09:16:40+00:00","author":{"name":"conciergedoc","url":"https:\/\/www.healthtap.com\/conciergedoc","image":"https:\/\/pbs.twimg.com\/profile_images\/712379480489238532\/lZXwKeRO_normal.jpg","description":"ceo http:\/\/housemed.co \/ founding physician @healthtap \/ cofounder @medicast (acq by @psjh) \/ @techstars alum \/ mentor @healthbox \/ @montgomerybell alum","id_on_source":"DrFerdowsi","tweeter_id":"471143047","geo":{"lt":null,"ln":null},"followers":7495},"tweet_id":"577760449577496576"},{"url":"https:\/\/twitter.com\/FutSciNow\/status\/577760257163792384","license":"datasift","rt":["isciencewriter"],"citation_ids":[3795202],"posted_on":"2015-03-17T09:15:54+00:00","author":{"name":"FutSci","url":"http:\/\/www.FutSci.com","image":"https:\/\/pbs.twimg.com\/profile_images\/456923434895671297\/X3GZfWYu_normal.jpeg","description":"Crowdfunding Community for Science Enthusiasts! Your opportunity to find out about the people behind the science and back innovative research important to you!","id_on_source":"FutSciNow","tweeter_id":"2391062042","geo":{"lt":null,"ln":null},"followers":8958},"tweet_id":"577760257163792384"},{"url":"https:\/\/twitter.com\/NextGEN_Ltd\/status\/577900368975302656","license":"datasift","rt":["PDRennert"],"citation_ids":[3795202],"posted_on":"2015-03-17T18:32:39+00:00","author":{"name":"\u0412\u043b\u0430\u0434","image":"https:\/\/pbs.twimg.com\/profile_images\/2342353963\/irjhyyc7ed67fugjx2fk_normal.jpeg","id_on_source":"NextGEN_Ltd","tweeter_id":"443359139","geo":{"lt":null,"ln":null},"followers":90},"tweet_id":"577900368975302656"},{"url":"https:\/\/twitter.com\/PDRennert\/status\/577896918484955136","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-17T18:18:56+00:00","author":{"name":"Paul D. Rennert","url":"http:\/\/www.aletabio.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2957136517\/1be33cdb3df6ddb405064a7b669446fc_normal.jpeg","description":"Co-founder, President & CSO, Aleta Biotherapeutics, http:\/\/aletabio.com -  Founder & Principal, SugarCone Biotech, commentary at http:\/\/sugarconebiotech.com","id_on_source":"PDRennert","tweeter_id":"1001726569","geo":{"lt":42.2001,"ln":-71.4245,"country":"US"},"followers":3650},"tweet_id":"577896918484955136"},{"url":"https:\/\/twitter.com\/HimaniTrivedi17\/status\/578561337556516864","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-19T14:19:06+00:00","author":{"name":"Himani Trivedi ","image":"http:\/\/pbs.twimg.com\/profile_images\/576986482465882112\/QpY33NVW_normal.jpeg","id_on_source":"HimaniTrivedi17","tweeter_id":"3083591197","followers":46},"tweet_id":"578561337556516864"},{"url":"https:\/\/twitter.com\/PiescheM\/status\/578624214200164353","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-19T18:28:57+00:00","author":{"name":"Matthias Piesche","url":"http:\/\/Gofundme.com\/immunotherapy","image":"https:\/\/pbs.twimg.com\/profile_images\/585519282508980225\/zir5JDT6_normal.jpg","description":"AssProf @ UCM. @DanaFarber\/@HarvardMed Alumnus. Interested in #cancer immunology & new biotechnologies. #Fundraising for cancer #immunotherapy research","id_on_source":"PiescheM","tweeter_id":"1852946341","geo":{"lt":-35.4264,"ln":-71.65542,"country":"CL"},"followers":1760},"tweet_id":"578624214200164353"},{"url":"https:\/\/twitter.com\/mrsgkr\/status\/578654070434631680","license":"datasift","rt":["PiescheM"],"citation_ids":[3795202],"posted_on":"2015-03-19T20:27:35+00:00","author":{"name":"Valerie","image":"https:\/\/pbs.twimg.com\/profile_images\/869947761965322241\/MFBNlTk2_normal.jpg","description":"Widowed, Mom of 6, g-ma to 12. Love my #SPNFamily \u2764\ufe0f","id_on_source":"mrsgkr","tweeter_id":"38442936","geo":{"lt":38.50038,"ln":-80.50009,"country":"US"},"followers":261},"tweet_id":"578654070434631680"},{"url":"https:\/\/twitter.com\/melanienaidoo_2\/status\/579163447872630784","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T06:11:40+00:00","author":{"name":"Melanie Naidoo","image":"https:\/\/pbs.twimg.com\/profile_images\/591658716967129088\/cCg3v5r9_normal.jpg","description":"Biochemistry Msc student & Qualified Microbiologist. Loves animals, science, travelling, good books,good movies, outdoor activities & marine life.","id_on_source":"melanienaidoo_2","tweeter_id":"3031550424","geo":{"lt":-29,"ln":24,"country":"ZA"},"followers":201},"tweet_id":"579163447872630784"},{"url":"https:\/\/twitter.com\/SantaCruzBio\/status\/579139234340036609","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T04:35:28+00:00","author":{"name":"Santa Cruz Biotech","url":"http:\/\/www.scbt.com","image":"https:\/\/pbs.twimg.com\/profile_images\/418791968311754753\/5uQ_TvLP_normal.jpeg","description":"Santa Cruz Biotechnology - Monoclonal Antibodies, RNAi, Biochemicals and CRISPR products for research. #Facebook: http:\/\/facebook.com\/santacruzbiotechnology","id_on_source":"SantaCruzBio","tweeter_id":"2273295432","geo":{"lt":32.78306,"ln":-96.80667,"country":"US"},"followers":19988},"tweet_id":"579139234340036609"},{"url":"https:\/\/twitter.com\/sjin_lee\/status\/579138495983161345","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T04:32:31+00:00","author":{"name":"SangJin","image":"https:\/\/pbs.twimg.com\/profile_images\/559296541744058368\/DMSmTfXV_normal.jpeg","description":"Imperial College London '13, University of Cambridge '14, Researcher at Macrogen.","id_on_source":"sjin_lee","tweeter_id":"2799669114","geo":{"lt":null,"ln":null},"followers":44},"tweet_id":"579138495983161345"},{"url":"https:\/\/twitter.com\/ivdacruz\/status\/579117091850215424","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T03:07:28+00:00","author":{"name":"Iv\u00e1n Dario Cruz P","url":"http:\/\/www.unal.edu.co\/iparm","image":"https:\/\/pbs.twimg.com\/profile_images\/40531022\/5cfe7ca9a08ab4bba384c8280f02bccf_normal.jpeg","description":"Inquieto permanente por la Educaci\u00f3n, las Ciencias y las nuevas Tecnolog\u00edas. IPARM UN","id_on_source":"ivdacruz","tweeter_id":"11297602","geo":{"lt":null,"ln":null},"followers":431},"tweet_id":"579117091850215424"},{"url":"https:\/\/twitter.com\/BIOCIENCIA2013\/status\/579100015227961345","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T01:59:37+00:00","author":{"name":"BIOCIENCIA","url":"http:\/\/musical100fm.com.ve\/","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000300217090\/9b25d5f581a95fff46afd4d8d0d0aad0_normal.jpeg","description":"Programa radial de enfermedades, avances tecnol\u00f3gicos, eventos cient\u00edficos de inter\u00e9s, noticias, entrevistas","id_on_source":"BIOCIENCIA2013","tweeter_id":"1672141952","geo":{"lt":10.46354,"ln":-64.1775,"country":"VE"},"followers":904},"tweet_id":"579100015227961345"},{"url":"https:\/\/twitter.com\/Mykalt45\/status\/579092984827772928","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T01:31:41+00:00","author":{"name":"Michael Torres, PhD","url":"https:\/\/t.co\/hLv1oICDyS","image":"http:\/\/pbs.twimg.com\/profile_images\/727832195415445505\/-KHYISIy_normal.jpg","description":"PhD in Cancer Biology\/Cystic Fibrosis researcher now, an avid Mac user, amateur music creator, art and fitness enthusiast. Trader. Co-founder.","id_on_source":"Mykalt45","tweeter_id":"289311242","followers":2516},"tweet_id":"579092984827772928"},{"url":"https:\/\/twitter.com\/MonzCobak\/status\/579091894237417472","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T01:27:21+00:00","author":{"name":"Monze Cobak","image":"http:\/\/pbs.twimg.com\/profile_images\/575169254661603328\/PhtmZ-Rd_normal.jpeg","description":"Bioengineering & 23 #MusicLover                 Do it with passion or not at all","id_on_source":"MonzCobak","tweeter_id":"84345423","geo":{"lt":"25.6764922","ln":"-100.3060829","country":"MX"},"followers":177},"tweet_id":"579091894237417472"},{"url":"https:\/\/twitter.com\/perepereden\/status\/579091395425624064","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-21T01:25:22+00:00","author":{"name":"pereden","url":"https:\/\/twitter.com\/i\/moments\/800257196453830656","image":"https:\/\/pbs.twimg.com\/profile_images\/825905160824119296\/0MkVi2jX_normal.jpg","description":"|\ud55c\uad6d\uc5b4OK || \u65e5\u672c\u8a9eOK| --------------------- I like science, music, and video games when I'm not being swamped by work.","id_on_source":"perepereden","tweeter_id":"2945729238","geo":{"lt":null,"ln":null},"followers":4766},"tweet_id":"579091395425624064"},{"url":"https:\/\/twitter.com\/Immune_News\/status\/579691560616476672","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-22T17:10:12+00:00","author":{"name":"ImmuneRegulationNews","url":"http:\/\/www.immuneregulationnews.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1121072009\/ImmuneRegulationNews_normal.jpg","description":"The online resource for the immune regulation community. Check out our sister publications, @InfDisease_News and @HumanImmuneNews.\nFB: http:\/\/ow.ly\/VGAoz","id_on_source":"Immune_News","tweeter_id":"154612604","geo":{"lt":null,"ln":null},"followers":3242},"tweet_id":"579691560616476672"},{"url":"https:\/\/twitter.com\/SjogrensForum\/status\/579754057272786944","license":"datasift","rt":["Immune_News"],"citation_ids":[3795202],"posted_on":"2015-03-22T21:18:33+00:00","author":{"name":"Sj\u00f6grens Forum","url":"http:\/\/www.sjogrensforum.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1083947731\/birds_normal.jpg","description":"Living Well With Sj\u00f6gren's Syndrome.","id_on_source":"SjogrensForum","tweeter_id":"169679081","geo":{"lt":null,"ln":null},"followers":3126},"tweet_id":"579754057272786944"},{"url":"https:\/\/twitter.com\/RTandBT\/status\/580072896892182528","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-23T18:25:30+00:00","author":{"name":"El sordo","image":"https:\/\/pbs.twimg.com\/profile_images\/584050793571033088\/ayDV1n-L_normal.jpg","description":"Clinical fellow | biotech investor, interested in public health | Opinions are my own | Tweets mostly about oncology, biotech, markets, and public health","id_on_source":"RTandBT","tweeter_id":"2522249316","geo":{"lt":null,"ln":null},"followers":357},"tweet_id":"580072896892182528"},{"url":"https:\/\/twitter.com\/dhovekamp42\/status\/580178140233859072","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-24T01:23:42+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"580178140233859072"},{"url":"https:\/\/twitter.com\/PrivilegeHealth\/status\/581145716808028161","license":"datasift","rt":["Immune_News"],"citation_ids":[3795202],"posted_on":"2015-03-26T17:28:30+00:00","author":{"name":"PrivilegeHealth.com","url":"http:\/\/psychbots.com","image":"https:\/\/pbs.twimg.com\/profile_images\/515449759213944833\/9YMzIu4e_normal.jpeg","description":"Concierge Longevity Care\/NLP\/Spontaneous Remission\/Indigenous Intel\/Ethnobotany\/Plant Meds\/CYP940\/AI\/Robots\/ML\/UX\/UI\/NLProc\/Data Solutions Software Arch\/App Dev","id_on_source":"PrivilegeHealth","tweeter_id":"2804187540","geo":{"lt":null,"ln":null},"followers":1360},"tweet_id":"581145716808028161"},{"url":"https:\/\/twitter.com\/celltherapynews\/status\/581893886743867392","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-28T19:01:28+00:00","author":{"name":"Cell Therapy News","url":"http:\/\/www.celltherapynews.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/748289281672642560\/ULgWUrkm_normal.jpg","description":"The online resource for cell and gene therapy research. Part of the http:\/\/connexoncreative.com\/ family.\nJoin us on Facebook: http:\/\/ow.ly\/4mUNF3","id_on_source":"celltherapynews","tweeter_id":"25326286","geo":{"lt":null,"ln":null},"followers":5743},"tweet_id":"581893886743867392"},{"url":"https:\/\/twitter.com\/BuckeyeMyeloma\/status\/581918124880064512","license":"datasift","rt":["celltherapynews"],"citation_ids":[3795202],"posted_on":"2015-03-28T20:37:47+00:00","author":{"name":"Craig Hofmeister","url":"http:\/\/ohiomyeloma.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000842174932\/59724ae276911fe037b0e94520386f64_normal.jpeg","description":"Hematologist at Ohio State. All things myeloma, primetime and beyond. Tweets are my own.","id_on_source":"BuckeyeMyeloma","tweeter_id":"2234845399","geo":{"lt":39.96118,"ln":-82.99879,"country":"US"},"followers":1001},"tweet_id":"581918124880064512"},{"url":"https:\/\/twitter.com\/Cytognos\/status\/585464745362358272","license":"datasift","citation_ids":[3795202],"posted_on":"2015-04-07T15:30:47+00:00","author":{"name":"Cytognos","url":"http:\/\/www.cytognos.com","image":"https:\/\/pbs.twimg.com\/profile_images\/435317300539846656\/xV6dyojn_normal.png","description":"Biotechnology company dedicated to the design and development of reagents and software in the flow cytometry field. EuroFlow\u2122 Supporting Company","id_on_source":"Cytognos","tweeter_id":"484698843","geo":{"lt":40.96882,"ln":-5.66388,"country":"ES"},"followers":524},"tweet_id":"585464745362358272"},{"url":"https:\/\/twitter.com\/Cytognos\/status\/585465867925856256","license":"datasift","citation_ids":[3795202],"posted_on":"2015-04-07T15:35:15+00:00","author":{"name":"Cytognos","url":"http:\/\/www.cytognos.com","image":"https:\/\/pbs.twimg.com\/profile_images\/435317300539846656\/xV6dyojn_normal.png","description":"Biotechnology company dedicated to the design and development of reagents and software in the flow cytometry field. EuroFlow\u2122 Supporting Company","id_on_source":"Cytognos","tweeter_id":"484698843","geo":{"lt":40.96882,"ln":-5.66388,"country":"ES"},"followers":524},"tweet_id":"585465867925856256"},{"url":"https:\/\/twitter.com\/JohnMakotoM\/status\/586382457227739137","license":"datasift","citation_ids":[3795202],"posted_on":"2015-04-10T04:17:26+00:00","author":{"name":"John.Makoto","image":"https:\/\/pbs.twimg.com\/profile_images\/2436788926\/he3w9r8uvb4ninucdjjn_normal.jpeg","description":"My interests are Biotechnology, Cancer, Genetics, Aptamer, Antisense, Ribozyme, Bioimfomatics, and ...","id_on_source":"JohnMakotoM","tweeter_id":"86538102","geo":{"lt":35.6895,"ln":139.69171,"country":"JP"},"followers":1606},"tweet_id":"586382457227739137"},{"url":"https:\/\/twitter.com\/Quantumash\/status\/586644932640673793","license":"datasift","rt":["JohnMakotoM"],"citation_ids":[3795202],"posted_on":"2015-04-10T21:40:25+00:00","author":{"name":"Ayesha","image":"https:\/\/pbs.twimg.com\/profile_images\/507177727380975616\/CYwNlpHR_normal.jpeg","description":"Epidemiology and Translational research enthusiast","id_on_source":"Quantumash","tweeter_id":"252258366","geo":{"lt":null,"ln":null},"followers":126},"tweet_id":"586644932640673793"},{"url":"https:\/\/twitter.com\/yannabraham\/status\/596691125605408769","license":"datasift","citation_ids":[3795202],"posted_on":"2015-05-08T15:00:24+00:00","author":{"name":"Yann Abraham","image":"https:\/\/pbs.twimg.com\/profile_images\/54359750\/spaceman_spiff_2_normal.jpg","description":"Biologist turned Bioinformatician with a knack for data visualization, trail running, moutain biking, bouldering and whisky tasting iwork@JnJ","id_on_source":"yannabraham","tweeter_id":"14814431","geo":{"lt":50.83333,"ln":4,"country":"BE"},"followers":586},"tweet_id":"596691125605408769"},{"url":"https:\/\/twitter.com\/papa_cannolo\/status\/596692191046705155","license":"datasift","rt":["yannabraham"],"citation_ids":[3795202],"posted_on":"2015-05-08T15:04:39+00:00","author":{"name":"Pap\u00e0 Spatatrac","image":"https:\/\/pbs.twimg.com\/profile_images\/847170734707392512\/TBTeHHVG_normal.jpg","description":"Grulli, sempre grulli, fortissimamente grulli.","id_on_source":"papa_cannolo","tweeter_id":"18680083","geo":{"lt":37.66414,"ln":12.58804,"country":"IT"},"followers":1622},"tweet_id":"596692191046705155"},{"url":"https:\/\/twitter.com\/xiangfang_n\/status\/606461185450328066","license":"datasift","citation_ids":[3795202],"posted_on":"2015-06-04T14:03:08+00:00","author":{"name":"fangxiang","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"xiangfang_n","tweeter_id":"2873598200","geo":{"lt":null,"ln":null},"followers":16},"tweet_id":"606461185450328066"},{"url":"https:\/\/twitter.com\/dhovekamp42\/status\/612723063570976769","license":"datasift","rt":["xiangfang_n"],"citation_ids":[3795202],"posted_on":"2015-06-21T20:45:36+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"612723063570976769"},{"url":"https:\/\/twitter.com\/ivdacruz\/status\/577554068157120512","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-16T19:36:34+00:00","author":{"name":"Iv\u00e1n Dario Cruz P","url":"http:\/\/www.unal.edu.co\/iparm","image":"https:\/\/pbs.twimg.com\/profile_images\/40531022\/5cfe7ca9a08ab4bba384c8280f02bccf_normal.jpeg","description":"Inquieto permanente por la Educaci\u00f3n, las Ciencias y las nuevas Tecnolog\u00edas. IPARM UN","id_on_source":"ivdacruz","tweeter_id":"11297602","geo":{"lt":null,"ln":null},"followers":431},"tweet_id":"577554068157120512"},{"url":"https:\/\/twitter.com\/isciencewriter\/status\/577758399628251136","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-17T09:08:31+00:00","author":{"name":"IScienceWriter","url":"http:\/\/www.internationalsciencewriter.com","image":"https:\/\/pbs.twimg.com\/profile_images\/743735975478595584\/E_dCeJAo_normal.jpg","description":"International Science Writer (ISW) creating and sharing up-to-the-minute  news about #lifescience, #biotech and #pharma industries.","id_on_source":"isciencewriter","tweeter_id":"469324230","geo":{"lt":51.95314,"ln":-0.26519,"country":"GB"},"followers":5389},"tweet_id":"577758399628251136"},{"url":"https:\/\/twitter.com\/DrSuePearson\/status\/577758399867330560","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-17T09:08:31+00:00","author":{"name":"Sue Pearson","url":"https:\/\/www.youtube.com\/watch?v=CmsMjUWQk_o","image":"https:\/\/pbs.twimg.com\/profile_images\/748424176147566592\/hmXmodzY_normal.jpg","description":"Writer for @GENBio, @ISciencewriter, science presenter @CambridgeTVnews.  #rebuildRNOH supporter. Tweets about #stemcells #biotech and stuff that interests me.","id_on_source":"DrSuePearson","tweeter_id":"45537659","geo":{"lt":51.95314,"ln":-0.26519,"country":"GB"},"followers":1172},"tweet_id":"577758399867330560"},{"url":"https:\/\/twitter.com\/CancerWallonia\/status\/577923170616893440","license":"datasift","rt":["NatureBiotech"],"citation_ids":[3795202],"posted_on":"2015-03-17T20:03:15+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":634},"tweet_id":"577923170616893440"},{"url":"https:\/\/twitter.com\/DrSuePearson\/status\/578116193883533313","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-18T08:50:16+00:00","author":{"name":"Sue Pearson","url":"https:\/\/www.youtube.com\/watch?v=CmsMjUWQk_o","image":"https:\/\/pbs.twimg.com\/profile_images\/748424176147566592\/hmXmodzY_normal.jpg","description":"Writer for @GENBio, @ISciencewriter, science presenter @CambridgeTVnews.  #rebuildRNOH supporter. Tweets about #stemcells #biotech and stuff that interests me.","id_on_source":"DrSuePearson","tweeter_id":"45537659","geo":{"lt":51.95314,"ln":-0.26519,"country":"GB"},"followers":1172},"tweet_id":"578116193883533313"},{"url":"https:\/\/twitter.com\/dhovekamp42\/status\/578131092831662080","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-18T09:49:28+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"578131092831662080"},{"url":"https:\/\/twitter.com\/isciencewriter\/status\/578620841543507968","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-19T18:15:33+00:00","author":{"name":"IScienceWriter","url":"http:\/\/www.internationalsciencewriter.com","image":"https:\/\/pbs.twimg.com\/profile_images\/743735975478595584\/E_dCeJAo_normal.jpg","description":"International Science Writer (ISW) creating and sharing up-to-the-minute  news about #lifescience, #biotech and #pharma industries.","id_on_source":"isciencewriter","tweeter_id":"469324230","geo":{"lt":51.95314,"ln":-0.26519,"country":"GB"},"followers":5389},"tweet_id":"578620841543507968"},{"url":"https:\/\/twitter.com\/fsgfon\/status\/578932429727076352","license":"datasift","citation_ids":[3795202],"posted_on":"2015-03-20T14:53:41+00:00","author":{"name":"Future Oncology Jnl","url":"http:\/\/www.futuremedicine.com\/loi\/fon","image":"https:\/\/pbs.twimg.com\/profile_images\/489034431470911488\/VL6M5Pdz_normal.jpeg","description":"Future Oncology | MEDLINE-indexed journal on advances in basic, translational and clinical oncology research | IF 2.131 | Published by Future Science Group","id_on_source":"fsgfon","tweeter_id":"2647607972","geo":{"lt":null,"ln":null},"followers":1522},"tweet_id":"578932429727076352"},{"url":"https:\/\/twitter.com\/Molecutools\/status\/579691642564820993","license":"datasift","rt":["Immune_News"],"citation_ids":[3795202],"posted_on":"2015-03-22T17:10:32+00:00","author":{"name":"Colm Ryan","url":"http:\/\/www.reagentbio.com","image":"https:\/\/pbs.twimg.com\/profile_images\/903986944677470210\/_fsYSMhU_normal.jpg","description":"CEO & cofounder \n| http:\/\/www.ELISAGenie.com | http:\/\/www.AntibodyGenie.com | http:\/\/www.AssayGenie.com","id_on_source":"Molecutools","tweeter_id":"2165144670","geo":{"lt":53.33306,"ln":-6.24889,"country":"IE"},"followers":1258},"tweet_id":"579691642564820993"},{"url":"http:\/\/twitter.com\/dhovekamp42\/statuses\/641183958974210048","license":"gnip","citation_ids":[3795202],"posted_on":"2015-09-08T09:39:03+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"641183958974210048"},{"url":"http:\/\/twitter.com\/dhovekamp42\/statuses\/647332395188928512","license":"gnip","citation_ids":[3795202],"posted_on":"2015-09-25T08:50:44+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"647332395188928512"},{"url":"http:\/\/twitter.com\/iRecRepPapers\/statuses\/712224836072792064","license":"gnip","citation_ids":[3795202],"posted_on":"2016-03-22T10:30:08+00:00","author":{"name":"RepSeqPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/698033041839554560\/2Lqbb8C9_normal.jpg","description":"A TwitterBot for papers on immune receptor repertoires. Curated by @ulrikstervbo. A general immunology bot: @immunol_papers. Bot setup: http:\/\/bit.ly\/1rwtvYu","id_on_source":"iRecRepPapers","tweeter_id":"4896068413","geo":{"lt":null,"ln":null},"followers":62},"tweet_id":"712224836072792064"},{"url":"http:\/\/twitter.com\/TumorImm_papers\/statuses\/712746786276835328","license":"gnip","citation_ids":[3795202],"posted_on":"2016-03-23T21:04:10+00:00","author":{"name":"TumorImmunoPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/741322452093931520\/rQvFtFTA_normal.jpg","description":"A TwitterBot for Cancer Immunology and Tolerance papers on #PubMed. Curated by @adamsnookphd","id_on_source":"TumorImm_papers","tweeter_id":"2829712275","geo":{"lt":null,"ln":null},"followers":661},"tweet_id":"712746786276835328"},{"url":"http:\/\/twitter.com\/dhovekamp42\/statuses\/748093781656870912","license":"gnip","citation_ids":[3795202],"posted_on":"2016-06-29T10:00:31+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"748093781656870912"},{"url":"http:\/\/twitter.com\/dhovekamp42\/statuses\/748559734899376128","license":"gnip","citation_ids":[3795202],"posted_on":"2016-06-30T16:52:03+00:00","author":{"name":"Dieter Hovekamp","image":"https:\/\/pbs.twimg.com\/profile_images\/417268395\/dh_tw_2009_normal.png","description":"born to be me, expect the worst - go for the best\n { views are my own - tweets are not advice }","id_on_source":"dhovekamp42","tweeter_id":"67066114","geo":{"lt":null,"ln":null},"followers":1612},"tweet_id":"748559734899376128"}],"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=604871582945684&id=364089560357222","license":"public","citation_ids":[3795202],"posted_on":"2015-03-16T18:52:13+00:00","summary":"Heading toward real immunotherapies for cancer!\n\nhttp:\/\/www.nature.com\/nbt\/journal\/vaop\/ncurrent\/full\/nbt.3147.html","author":{"name":"H\u00e9bert Lab","url":"https:\/\/www.facebook.com\/364089560357222","facebook_wall_name":"H\u00e9bert Lab","image":"https:\/\/graph.facebook.com\/364089560357222\/picture","id_on_source":"364089560357222"}}],"googleplus":[{"title":"\"Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative...","url":"https:\/\/plus.google.com\/117538785674686050797\/posts\/NZvE9tczMHP","license":"public","citation_ids":[3795202],"posted_on":"2015-03-17T15:01:09+00:00","summary":"\"Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative... &quot;Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice&quot;\ufeff www.nature.com","author":{"name":"Advantage Integral","url":"https:\/\/plus.google.com\/117538785674686050797","image":"https:\/\/lh6.googleusercontent.com\/-t_6bFLockUM\/AAAAAAAAAAI\/AAAAAAAAABU\/KEQkvklvBO8\/photo.jpg?sz=50","id_on_source":"117538785674686050797"}}],"weibo":[{"url":"http:\/\/weibo.com\/1978045234\/C9L3Y5LMR","license":"public","citation_ids":[3795202],"posted_on":"2015-03-22T10:16:00+00:00","summary":"\u6700\u8fd1\u5f88\u70ed\u554a\/\/@\u6765\u90a6\u7f51:\u3010\u80bf\u7624\u7279\u5f02\u6027T\u7ec6\u80de\u53d7\u4f53\u7b5b\u9009\u65b9\u6cd5\u3011\u5bfb\u627e\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u7684\u9ad8\u4eb2\u548c\u529bT\u7ec6\u80de\u53d7\u4f53\u662f\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u74f6\u9888\u6240\u5728\u3002\u73b0\u5982\u4eca\u7814\u7a76\u8005\u501f\u52a9\u4e8e\u4eba\u6e90\u5316\u5c0f\u9f20\u6a21\u578b\uff0c\u627e\u5230\u4e86\u591a\u79cd\u5bf9\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u5177\u6709\u9ad8\u4eb2\u548c\u529b\u7684T\u7ec6\u80de\u53d7\u4f53\uff0c\u4e3a\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u518d\u6dfb\u65b0\u7684\u6b66\u5668\u3002http:\/\/t.cn\/RAZGiMX","author":{"name":"\u7d2b\u5cf0\u8428\u6469\u8036","image":"http:\/\/tp3.sinaimg.cn\/1978045234\/50\/1299380143\/0","id_on_source":"1978045234","followers":84}},{"url":"http:\/\/weibo.com\/5255340762\/C9L1XmFHE","license":"public","citation_ids":[3795202],"posted_on":"2015-03-22T10:11:03+00:00","summary":"\/\/@\u6765\u90a6\u7f51:\u3010\u80bf\u7624\u7279\u5f02\u6027T\u7ec6\u80de\u53d7\u4f53\u7b5b\u9009\u65b9\u6cd5\u3011\u5bfb\u627e\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u7684\u9ad8\u4eb2\u548c\u529bT\u7ec6\u80de\u53d7\u4f53\u662f\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u74f6\u9888\u6240\u5728\u3002\u73b0\u5982\u4eca\u7814\u7a76\u8005\u501f\u52a9\u4e8e\u4eba\u6e90\u5316\u5c0f\u9f20\u6a21\u578b\uff0c\u627e\u5230\u4e86\u591a\u79cd\u5bf9\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u5177\u6709\u9ad8\u4eb2\u548c\u529b\u7684T\u7ec6\u80de\u53d7\u4f53\uff0c\u4e3a\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u518d\u6dfb\u65b0\u7684\u6b66\u5668\u3002http:\/\/t.cn\/RAZGiMX","author":{"name":"\u5e03\u9053\u78a7\u6d6a","image":"http:\/\/tp3.sinaimg.cn\/5255340762\/50\/5703219975\/1","id_on_source":"5255340762","followers":7}},{"url":"http:\/\/weibo.com\/2238278172\/C9Kt4FI7G","license":"public","citation_ids":[3795202],"posted_on":"2015-03-22T08:45:04+00:00","summary":"\u3010\u80bf\u7624\u7279\u5f02\u6027T\u7ec6\u80de\u53d7\u4f53\u7b5b\u9009\u65b9\u6cd5\u3011\u5bfb\u627e\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u7684\u9ad8\u4eb2\u548c\u529bT\u7ec6\u80de\u53d7\u4f53\u662f\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u74f6\u9888\u6240\u5728\u3002\u73b0\u5982\u4eca\u7814\u7a76\u8005\u501f\u52a9\u4e8e\u4eba\u6e90\u5316\u5c0f\u9f20\u6a21\u578b\uff0c\u627e\u5230\u4e86\u591a\u79cd\u5bf9\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u5177\u6709\u9ad8\u4eb2\u548c\u529b\u7684T\u7ec6\u80de\u53d7\u4f53\uff0c\u4e3a\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u518d\u6dfb\u65b0\u7684\u6b66\u5668\u3002http:\/\/t.cn\/RAZGiMX","author":{"name":"\u6765\u90a6\u7f51","url":"http:\/\/www.labome.com\/","image":"http:\/\/tp1.sinaimg.cn\/2238278172\/50\/5605269192\/1","description":"\u4e86\u89e3\u751f\u547d, \u4e86\u89e3\u79d1\u7814, \u4e86\u89e3\u521b\u4e1a","id_on_source":"2238278172","followers":15069}},{"url":"http:\/\/weibo.com\/2027358433\/C9LYL8IZ3","license":"public","citation_ids":[3795202],"posted_on":"2015-03-22T12:35:55+00:00","summary":"\/\/@\u6765\u90a6\u7f51:\u3010\u80bf\u7624\u7279\u5f02\u6027T\u7ec6\u80de\u53d7\u4f53\u7b5b\u9009\u65b9\u6cd5\u3011\u5bfb\u627e\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u7684\u9ad8\u4eb2\u548c\u529bT\u7ec6\u80de\u53d7\u4f53\u662f\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u74f6\u9888\u6240\u5728\u3002\u73b0\u5982\u4eca\u7814\u7a76\u8005\u501f\u52a9\u4e8e\u4eba\u6e90\u5316\u5c0f\u9f20\u6a21\u578b\uff0c\u627e\u5230\u4e86\u591a\u79cd\u5bf9\u80bf\u7624\u7279\u5f02\u6027\u6297\u539f\u5177\u6709\u9ad8\u4eb2\u548c\u529b\u7684T\u7ec6\u80de\u53d7\u4f53\uff0c\u4e3a\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u518d\u6dfb\u65b0\u7684\u6b66\u5668\u3002http:\/\/t.cn\/RAZGiMX","author":{"name":"\u7099\u94ed\u548f\u6625","image":"http:\/\/tp2.sinaimg.cn\/2027358433\/50\/5709474135\/1","description":"\u55e1\u561b\u5462\u53ed\u54aa\u54de","id_on_source":"2027358433","geo":{"lt":"36.0000001","ln":"118.9999999","country":"CN"},"followers":179}}]}}